Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/24/2012 | CN101955905B Bacterial strain for producing Escherichia coli K88ac-K99-ST1-LTB quadrivalent gene engineering inactivated vaccines and inactivated vaccine production method |
10/24/2012 | CN101889593B Functional incense and preparation method and application thereof |
10/24/2012 | CN101880302B Polyhydroxylated sterol derivative as well as preparation and application thereof |
10/24/2012 | CN101766690B Multipurpose utilization method for improving the value of schisandra chinensis medicinal material |
10/24/2012 | CN101744946B Chinese medicinal composition and detection method for Chinese medicinal composition preparation |
10/24/2012 | CN101711796B Application of scullcapflavone in preparing medicament for treating enterovirus infection |
10/24/2012 | CN101607954B Danshensu derivative, preparation method thereof, and application thereof in pharmacy |
10/24/2012 | CN101549154B Compositions comprising neisseria meningitidis antigens from serogroups B and C as well as a further antigen |
10/24/2012 | CN101531578B Method for preparing axial chirality diaromatic compound with optical activity |
10/24/2012 | CN101374844B Pyrrolopyridazinone compound |
10/24/2012 | CN101321861B Method for generating dendritic cells employing decreased temperature |
10/24/2012 | CN101180076B Use of an influenza virus an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response |
10/24/2012 | CN101065131B Antimicrobial agents |
10/23/2012 | US8293895 Carbapenem derivatives |
10/23/2012 | US8293745 Use of imatinib to treat liver disorders and viral infections |
10/23/2012 | US8293703 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
10/23/2012 | US8293283 Methods for treating oral cavity infections with chlorine dioxide |
10/23/2012 | US8293273 Controlled release and taste masking oral pharmaceutical composition |
10/23/2012 | US8293268 Local administration of gallium compositions to treat pain |
10/23/2012 | CA2679626C Fluoroquinolones for treating, reducing, ameliorating, or preventing infections caused by antibacterial-drug resistant bacteria |
10/23/2012 | CA2555279C Azepinoindole derivatives as pharmaceutical agents |
10/23/2012 | CA2469599C Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
10/23/2012 | CA2460749C Glycoconjugate vaccines for use in immune-compromised populations |
10/23/2012 | CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3 |
10/23/2012 | CA2366216C Polycationic carbohydrates as immunostimulants in vaccines |
10/18/2012 | WO2012142523A2 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment |
10/18/2012 | WO2012142367A2 Compositions and methods for treatment of pulmonary diseases and conditions |
10/18/2012 | WO2012142080A1 Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
10/18/2012 | WO2012141989A2 Immunogens |
10/18/2012 | WO2012141773A1 Methods and compositions for reducing shiga toxin induced toxicity in mammals |
10/18/2012 | WO2012141704A1 Compounds for the treatment of hepatitis c |
10/18/2012 | WO2012141674A2 Compositions and methods relating to argininosuccinate synthetase |
10/18/2012 | WO2012141540A2 Novel isolated lactobacillus fermentum strain having viral infection inhibitory activity |
10/18/2012 | WO2012141338A1 6,7 - dihydroimidazo [2, 1 - b] [1, 3] oxazine bactericides |
10/18/2012 | WO2012140620A1 Compositions for preventing and/or treating an infection by an hiv-1 virus |
10/18/2012 | WO2012140504A1 Therapeutic compounds |
10/18/2012 | WO2012140365A1 Use of calixarenes associated with an antibiotic in the treatment of bacterial infections |
10/18/2012 | WO2012140272A1 Treatment of microbial infections |
10/18/2012 | WO2012140082A1 Treatment of hepatitis c virus infection with alisporivir |
10/18/2012 | WO2012139930A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors |
10/18/2012 | WO2012139918A1 Methods for treating bacterial infection |
10/18/2012 | WO2012139521A1 Traditional chinese medicinal composition for preventing and treating influenza a and preparation method therefor and use thereof |
10/18/2012 | WO2012139519A1 Cyclic peptide and medical use thereof |
10/18/2012 | WO2012139485A1 Oral solid preparation of compound antituberculosis drug and preparation method thereof |
10/18/2012 | WO2012139424A1 Crystalline forms of tebipenem, preparation methods and uses thereof in the preparation of medicines |
10/18/2012 | WO2012139281A1 Adjuvant based on hiv tat and uses thereof |
10/18/2012 | WO2012139225A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a |
10/18/2012 | WO2012139179A1 Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract |
10/18/2012 | WO2012095388A3 Compounds for treatment of feline leukemia in felidae |
10/18/2012 | WO2012088577A3 Recombinant mycobacterium sp. protein, immunodiagnostic test and tuberculosis vaccine |
10/18/2012 | WO2012073214A4 Heptose derivatives for use in the treatment of bacterial infections |
10/18/2012 | US20120266262 Methods and compositions relating to zpa polypeptides |
10/18/2012 | US20120264966 Sulfur-containing phospholipid derivatives |
10/18/2012 | US20120264820 Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of HIV infection and other pathologies |
10/18/2012 | US20120264818 Topical Compositions with Cannabis Extracts |
10/18/2012 | US20120264814 Isolation, Cloning, Sequencing and Functional analysis of ss-casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis) |
10/18/2012 | US20120264802 Photosensitizers for targeted photodynamic therapy |
10/18/2012 | US20120264798 Prodrugs of inhibitors of plasma kallikrein |
10/18/2012 | US20120264793 Pharmaceutical Use of 2',2-Bis-Thiazole Non-Nucleoside Compounds as Hepatitis C Virus Inhibitor |
10/18/2012 | US20120264780 Solid compositions |
10/18/2012 | US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase |
10/18/2012 | US20120264747 Triazolopyridine jak inhibitor compounds and methods |
10/18/2012 | US20120264740 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
10/18/2012 | US20120264737 Heterocyclic Modulators of Lipid Synthesis |
10/18/2012 | US20120264729 Co-crystals and salts of ccr3-inhibitors |
10/18/2012 | US20120264727 Novel cephalosporin derivatives and pharmaceutical compositions thereof |
10/18/2012 | US20120264726 Methods of sensitizing drug resistant microorganisms using methylsulfonylmethane (msm) |
10/18/2012 | US20120264724 Antimicrobial agents based on hemin derivatives |
10/18/2012 | US20120264717 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives |
10/18/2012 | US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
10/18/2012 | US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
10/18/2012 | US20120264711 Antiviral compounds |
10/18/2012 | US20120264710 Systems and Methods for Detecting hENT1 Expression in Hematological Disorders |
10/18/2012 | US20120264709 Nucleotide and oligonucleotide prodrugs |
10/18/2012 | US20120264707 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
10/18/2012 | US20120264705 Antimicrobial compositions comprising 15-hetre and methods of use thereof |
10/18/2012 | US20120264704 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors |
10/18/2012 | US20120264689 Methods and compositions for skin regeneration |
10/18/2012 | US20120264679 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
10/18/2012 | US20120264678 Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases |
10/18/2012 | US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
10/18/2012 | US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
10/18/2012 | US20120263782 Methods and compositions for treating hiv infection |
10/18/2012 | US20120263780 Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same |
10/18/2012 | US20120263765 Agents from cells |
10/18/2012 | US20120263763 Regenerative materials |
10/18/2012 | US20120263756 Vaccines containing canine parvovirus genetic variants |
10/18/2012 | US20120263755 Methods and compositions for eliciting an immune response against hepatitis b virus |
10/18/2012 | US20120263754 Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines |
10/18/2012 | US20120263752 Herpes Simplex Virus Vaccines |
10/18/2012 | US20120263750 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites |
10/18/2012 | US20120263747 Albumin-Fused Anti-Angiogenesis Peptides |
10/18/2012 | US20120263745 Antichlamydial agents |
10/18/2012 | US20120263744 Compositions And Methods Involving Respiratory Syncytial Virus Subgroup B Strain 9320 |
10/18/2012 | US20120263743 Influenza hemagglutinin compositions and uses thereof |
10/18/2012 | US20120263738 Multiplex dicer substrate rna interference molecules having joining sequences |
10/18/2012 | US20120263736 Method for predicting and treating a sterile inflammation and discriminating between sterile and infective inflammation |
10/18/2012 | US20120263734 Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus Infections |
10/18/2012 | US20120263726 Pharmaceutical composition and method of inhibiting of production or amplifying of elimination of P24 protein |
10/18/2012 | US20120263725 Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV |